Matthew Kulke, MD | Authors

Neuroendocrine Tumors: Answers-and Questions

September 15, 2014

The relative abundance of new data on the biological underpinnings of neuroendocrine tumors, combined with clinical trial data supporting new treatment options, is a clear sign of progress. Yet, as is so often the case, these recent studies have generated a multitude of new and different questions.